M7T · ASX

Mach7 Technologies Ltd. (ASX:M7T)

AU$0.33

 0.005 (1.538%)
ASX:Live
20/12/2024 04:10:10 PM
Volume Spike HALO Ords HALO Earnings Momentum HALO Consensus Value GROWTH AUS +3
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

M7T Overview

M7T Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Neutral

About M7T

Website

Mach7 Technologies Ltd.

Telephone

1.802.861.7745

Address

Suite 210 120 Kimball Avenue South Burlington, VT 05403

Description

Mach7 Technologies Ltd. engages in the development and commercialization of medical imaging and data management software solutions for global healthcare enterprises. It operates through the following geographical segments: North America, Asia Pacific, Middle East, and Europe and Other Regions. The company was founded by Ravi Krishnan in 2007 and is headquartered in South Burlington, VT.

M7T Price Chart

Key Stats

Market Cap

AU$79.61M

PE

94.40

EV/EBITDA

17.9

Dividends Overview

DIV Yield

.0%

Franking

%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.31 - 0.81

Trade Value (12mth)

AU$32,320.00

1 week

0%

1 month

-9.72%

YTD

-57.79%

1 year

-59.12%

All time high

719.39

Key Fundamentals

EPS 3 yr Growth

-17.00%

EBITDA Margin

-9.70%

Operating Cashflow

$3m

Free Cash Flow Return

6.10%

ROIC

-14.10%

Interest Coverage

-45.90

Quick Ratio

2.20

Other Data

Shares on Issue (Fully Dilluted)

241m

HALO Sector

Technology

Next Company Report Date

27-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.14

M7T Announcements

Latest Announcements

Date Announcements

17 December 24

Change of Director's Interest Notice - ML

×

Change of Director's Interest Notice - ML

11 December 24

Notification regarding unquoted securities - M7T

×

Notification regarding unquoted securities - M7T

11 December 24

Change of Director's Interest Notice - ML

×

Change of Director's Interest Notice - ML

09 December 24

Change of Director's Interest Notice - RB

×

Change of Director's Interest Notice - RB

04 December 24

Change of Director's Interest Notice - RB

×

Change of Director's Interest Notice - RB

03 December 24

Change of Director's Interest Notice RB

×

Change of Director's Interest Notice RB

29 November 24

Change of Director's Interest Notice RT

×

Change of Director's Interest Notice RT

28 November 24

AGM 2024 - Chair & CEO Addresses & Presentation

×

AGM 2024 - Chair & CEO Addresses & Presentation

28 November 24

Results of Annual General Meeting 2024

×

Results of Annual General Meeting 2024

25 November 24

Notification regarding unquoted securities - M7T

×

Notification regarding unquoted securities - M7T

20 November 24

Notification of cessation of securities - M7T

×

Notification of cessation of securities - M7T

20 November 24

Change of Director's Interest Notice x 3

×

Change of Director's Interest Notice x 3

20 November 24

Notification regarding unquoted securities - M7T

×

Notification regarding unquoted securities - M7T

18 November 24

Change in substantial shareholding from AEF

×

Change in substantial shareholding from AEF

31 October 24

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

31 October 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 October 24

Annual Report to Shareholders FY2024

×

Annual Report to Shareholders FY2024

30 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

28 October 24

Mach7 Signs A$4.3m Licence Expansion And Renewals

×

Mach7 Signs A$4.3m Licence Expansion And Renewals

24 October 24

Wilsons Drug and Device Conference Presentation

×

Wilsons Drug and Device Conference Presentation

14 October 24

Notification of cessation of securities - M7T

×

Notification of cessation of securities - M7T

11 October 24

Notice of Q1 FY25 Result & Investor Webinar

×

Notice of Q1 FY25 Result & Investor Webinar

03 October 24

Date of AGM

×

Date of AGM

01 October 24

Notification of cessation of securities - M7T

×

Notification of cessation of securities - M7T

01 October 24

Change of Director's Interest Notice - ML

×

Change of Director's Interest Notice - ML

M7T Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.00 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.00 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 56.1 74.9 -652.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A 94.4 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A 17.9 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.02 0.01 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.02 -0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 302.9 -21.9 -134.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock 5.1 -2.0 2.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.24 0.25 0.21 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.06 0.10 0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 85.1 58.7 -0.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 238 239 241 Lock Lock Lock
Basic m Lock Lock Lock Lock 238 239 241 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 27 30 29 Lock Lock Lock
     Growth % Lock Lock Lock Lock 42.3 11.0 -3.1 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 6 6 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -3 -1 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 66.7 47.9 -213.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -9.5 -4.5 -14.4 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 110 104 114 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 2 2 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 546.6 -28.2 -270.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 8.6 5.5 -9.7 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 9 9 7 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -7 -7 -10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 34.2 -3.8 -43.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -25.0 -23.4 -34.7 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -6 -7 -10 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 -6 -2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -4 -1 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 55.5 74.9 -660.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -15.4 -3.5 -27.4 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 6 -3 3 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 6 -3 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 325.0 -150.1 211.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 -0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 26 23 26 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 79 82 73 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -24 -22 -25 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 21 23 21 Lock Lock Lock
Equity $m Lock Lock Lock Lock 58 59 52 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 60 60 53 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.4 1.6 -12.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -5.3 -1.3 -10.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -7.1 -1.8 -15.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -11.4 -11.7 -17.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -7.1 -1.7 -14.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 10.8 -4.4 6.1 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock 41.9 24.9 -45.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -10.5 -13.3 8.8 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -41.8 -37.3 -48.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 3.1 2.3 2.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.1 2.3 2.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 80.3 67.5 78.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 61.4 -17.6 22.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.8 3.6 3.5 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.2 1.5 1.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 2.7 2.5 2.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.3 0.4 0.4 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.3 0.4 0.4 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -23.4 -22.1 -33.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -8.0 -8.1 -13.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -5.3 -1.3 -10.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 1.4 1.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -7.1 -1.8 -15.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -7.1 -1.8 -15.4 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 76.8 100.2 105.2 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 76.8 100.2 105.2 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 6.0 8.5 8.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 70.8 91.6 96.6 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

%

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.14%

Value ($M)

0

Prior Change

N/A

7 Day Change

0.10%

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

M7T Shortsell

Frequently Asked Questions

The current share price of Mach7 Technologies Ltd. (M7T:ASX) is AU$0.33.
The 52-week high share price for Mach7 Technologies Ltd. (M7T:ASX) is AU$0.81.
The 52-week low share price for Mach7 Technologies Ltd. (M7T:ASX)? is AU$0.31.
The current TTM dividend payout for Mach7 Technologies Ltd. (M7T:ASX) is 0.00.
Mach7 Technologies Ltd. (M7T:ASX) does not pay a dividend.
Mach7 Technologies Ltd. (M7T:ASX) does not offer franking credits.
Mach7 Technologies Ltd. (M7T:ASX) is classified in the Technology.
The current P/E ratio for Mach7 Technologies Ltd. (M7T:ASX) is 94.40.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.